Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.

Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Graß S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Hünig T, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D.

Haematologica. 2019 Dec 26. pii: haematol.2019.229252. doi: 10.3324/haematol.2019.229252. [Epub ahead of print]

2.

Cytokine profiles of umbilical cord blood mononuclear cells upon in vitro stimulation with lipopolysaccharides of different vaginal gram-negative bacteria.

Reuschel E, Toelge M, Entleutner K, Deml L, Seelbach-Goebel B.

PLoS One. 2019 Sep 19;14(9):e0222465. doi: 10.1371/journal.pone.0222465. eCollection 2019.

3.

Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.

Reuschel E, Jilg W, Seelbach-Goebel B, Deml L.

PLoS One. 2019 Feb 22;14(2):e0212800. doi: 10.1371/journal.pone.0212800. eCollection 2019.

4.

Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.

Banas B, Steubl D, Renders L, Chittka D, Banas MC, Wekerle T, Koch M, Witzke O, Mühlfeld A, Sommerer C, Habicht A, Hugo C, Hünig T, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Krämer BK, Krüger B.

Transpl Int. 2018 Apr;31(4):436-450. doi: 10.1111/tri.13110. Epub 2018 Jan 16.

5.

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.

Barabas S, Spindler T, Kiener R, Tonar C, Lugner T, Batzilla J, Bendfeldt H, Rascle A, Asbach B, Wagner R, Deml L.

BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y.

6.

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.

Banas B, Böger CA, Lückhoff G, Krüger B, Barabas S, Batzilla J, Schemmerer M, Köstler J, Bendfeldt H, Rascle A, Wagner R, Deml L, Leicht J, Krämer BK.

BMC Immunol. 2017 Mar 7;18(1):15. doi: 10.1186/s12865-017-0194-z.

7.

Functional impairment of CMV-reactive cellular immunity during pregnancy.

Reuschel E, Barabas S, Zeman F, Bendfeldt H, Rascle A, Deml L, Seelbach-Goebel B.

J Med Virol. 2017 Feb;89(2):324-331. doi: 10.1002/jmv.24639. Epub 2016 Sep 7.

PMID:
27447923
8.

The effect of Indomethacin and Betamethasone on the cytokine response of human neonatal mononuclear cells to gram-positive bacteria.

Ernst W, Kusi E, Fill Malfertheiner S, Reuschel E, Deml L, Seelbach-Göbel B.

Cytokine. 2015 May;73(1):91-100. doi: 10.1016/j.cyto.2015.01.023. Epub 2015 Mar 2.

PMID:
25743243
9.

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.

Fitzpatrick LR, Deml L, Hofmann C, Small JS, Groeppel M, Hamm S, Lemstra S, Leban J, Ammendola A.

Inflamm Bowel Dis. 2010 Oct;16(10):1763-77. doi: 10.1002/ibd.21264.

PMID:
20310011
10.

Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.

Baiker A, Haase R, Eberle J, Vizoso Pinto MG, Pfrepper KI, Petrich A, Deml L, Campe H, Nitschko H, Jaeger G.

Virol J. 2010 Mar 6;7:54. doi: 10.1186/1743-422X-7-54.

11.

Inhibition of Legionella pneumophila PCR in respiratory samples: a quantitative approach.

Kern M, Böhm S, Deml L, Wolf H, Reischl U, Niller HH.

J Microbiol Methods. 2009 Nov;79(2):189-93. doi: 10.1016/j.mimet.2009.08.020. Epub 2009 Sep 10.

PMID:
19747952
12.

Urea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein.

Barabas S, Gary R, Bauer T, Lindner J, Lindner P, Weinberger B, Jilg W, Wolf H, Deml L.

PLoS Pathog. 2008 Nov;4(11):e1000198. doi: 10.1371/journal.ppat.1000198. Epub 2008 Nov 7.

13.

Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes.

Speth C, Bredl S, Hagleitner M, Wild J, Dierich M, Wolf H, Schroeder J, Wagner R, Deml L.

Virology. 2008 Dec 5;382(1):46-58. doi: 10.1016/j.virol.2008.08.043. Epub 2008 Oct 21.

14.

CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.

Lindner J, Zehentmeier S, Franssila R, Barabas S, Schroeder J, Deml L, Modrow S.

J Infect Dis. 2008 Dec 1;198(11):1677-84. doi: 10.1086/592985.

15.

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K.

Virology. 2006 Jul 20;351(1):133-44. Epub 2006 Apr 17.

16.

CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.

Lindner J, Barabas S, Saar K, Altmann D, Pfister A, Fleck M, Deml L, Modrow S.

J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):356-61.

PMID:
16316401
17.

Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Deml L, Aigner M, Decker J, Eckhardt A, Schütz C, Mittl PR, Barabas S, Denk S, Knoll G, Lehn N, Schneider-Brachert W.

Infect Immun. 2005 Aug;73(8):4732-42.

18.

Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells.

Kranzer K, Söllner L, Aigner M, Lehn N, Deml L, Rehli M, Schneider-Brachert W.

Infect Immun. 2005 Jul;73(7):4180-9.

19.

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses.

Deml L, Speth C, Dierich MP, Wolf H, Wagner R.

Mol Immunol. 2005 Feb;42(2):259-77. Review.

PMID:
15488613
20.

Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori.

Kranzer K, Eckhardt A, Aigner M, Knoll G, Deml L, Speth C, Lehn N, Rehli M, Schneider-Brachert W.

Infect Immun. 2004 Aug;72(8):4416-23.

21.
23.

Application of single-cell cultures of mouse splenocytes as an assay system to analyze the immunomodulatory properties of bacterial components.

Deml L, Aigner M, Eckhardt A, Decker J, Lehn N, Schneider-Brachert W.

Methods Mol Med. 2004;94:159-75.

PMID:
14959828
24.
25.

Co-influence of transgene expression in mammalian cells. Mutual influence of transgenes on their expression in mammalian cells.

Kofman A, Graf M, Deml L, Kharazova A, Wolf H, Wagner R.

Tsitologiia. 2003;45(4):387-91.

PMID:
14520870
26.

Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation.

Kofman A, Graf M, Deml L, Wolf H, Wagner R.

Tsitologiia. 2003;45(1):94-100.

PMID:
12683242
27.

HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.

Kofman A, Graf M, Bojak A, Deml L, Bieler K, Kharazova A, Wolf H, Wagner R.

Tsitologiia. 2003;45(1):86-93.

PMID:
12683241
28.

Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines.

Bojak A, Wild J, Deml L, Wagner R.

Intervirology. 2002;45(4-6):275-86.

PMID:
12566710
29.

CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.

Obermeier F, Dunger N, Deml L, Herfarth H, Schölmerich J, Falk W.

Eur J Immunol. 2002 Jul;32(7):2084-92.

30.

The past, present and future of HIV-vaccine development: a critical view.

Bojak A, Deml L, Wagner R.

Drug Discov Today. 2002 Jan 1;7(1):36-46. Review.

PMID:
11790602
31.
32.

Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.

Sester M, Sester U, Köhler H, Schneider T, Deml L, Wagner R, Mueller-Lantzsch N, Pees HW, Meyerhans A.

AIDS. 2000 Dec 1;14(17):2653-60.

PMID:
11125883
33.
34.

Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.

Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.

Virology. 1999 Nov 25;264(2):289-97.

35.

Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells.

Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.

J Virol Methods. 1999 May;79(2):205-17.

PMID:
10381090
36.
37.

Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins.

Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.

Clin Chem Lab Med. 1999 Mar;37(3):199-204.

PMID:
10353461
38.

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection.

Wagner R, Teeuwsen VJ, Deml L, Notka F, Haaksma AG, Jhagjhoorsingh SS, Niphuis H, Wolf H, Heeney JL.

Virology. 1998 May 25;245(1):65-74.

39.
42.

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.

Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H.

Virology. 1996 Jun 1;220(1):128-40.

43.

Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques.

Wagner R, Deml L, Notka F, Wolf H, Schirmbeck R, Reimann J, Teeuwsen V, Heeney J.

Intervirology. 1996;39(1-2):93-103. Review.

PMID:
8957675
44.

A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study.

Wagner R, Deml L, Teeuwsen V, Heeney J, Yiming S, Wolf H.

Antibiot Chemother (1971). 1996;48:68-83. Review. No abstract available.

PMID:
8726508
45.

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.

Schirmbeck R, Deml L, Melber K, Wolf H, Wagner R, Reimann J.

Vaccine. 1995 Jun;13(9):857-65.

PMID:
7483809
46.
47.

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.

Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H.

Virology. 1994 Apr;200(1):162-75. Erratum in: Virology 1994 Jun;201(2):424.

PMID:
7510434
48.

Polyvalent, recombinant HIV-1 virus-like particles: novel HIV-1 vaccine strategies.

Wagner R, Deml L, Wolf H.

Antibiot Chemother (1971). 1994;46:48-61. Review. No abstract available.

PMID:
7826039
50.

[Comparatice studies on enzyme activity in blood plasma and serum in man, rabbits and rats].

Methfessel J, Deml L.

Z Klin Chem Klin Biochem. 1967 Nov;5(6):287-90. German. No abstract available.

PMID:
5596918

Supplemental Content

Support Center